Global Pharma and Biotech Summit

Whether you want to revisit a specific keynote or catch up on a panel, all sessions are available to watch on-demand via the agenda page. Not a registered delegate? Get a video on-demand pass here to unlock access to all sessions.

Changing patient behaviour, new computing power, rising political scrutiny and new global centres of innovation are redrawing pharma sector operating models. The result is not simply disruption, but also opportunity for those companies, investors and policymakers that can move early, think across silos, and build models that help take advantage of shifts. 

The Global Pharma and Biotech Summit, organised by the Financial Times, convened the leaders defining that next phase. Over two days at our annual London event, they examined topics including Europe’s competitiveness, the US’s post-Most Favored Nation pricing regime, the latest applications of AI, direct access to medications, China’s influence and the future of the NHS. Each of the event sessions addressed ways the pharma and biotech sectors can turn scientific momentum into commercial success, build stronger systems, and deliver better outcomes for patients.

Key themes discussed

Geopolitical and Economic Disruptions:

The escalating political and economic tension between the US and China raises concerns about strategic de-coupling, affecting global R&D, manufacturing, and market access.

The Rise of New Pharma Powers:

India is recognised as a rapidly growing biotech hub, maturing beyond generic drugs and China is transitioning from a licensing market to a global innovation force.

Regulation of Emerging Technologies:

 Regulators face challenges assessing complex technologies with limited transparency. Defining "evidence" in the context of AI and RWE is also a concern.

Drug Pricing and Reimbursement Pressures:

Balancing drug affordability with the need to fund innovation is a central challenge. 

Patient Empowerment and Digital Health:

Apps, sensors, and digital platforms are reshaping patient interactions with therapies. 

Gain access to all in-person session recordings to watch on-demand for 90 days.

Speaking Opportunities

Ben Graham
ben.graham@ft.com

Sponsorship

Rachel Joy
rachel.joy@ft.com  

Delegate Services 

Billy Warville
 william.warville@ft.com